The biochemical and hematological assessment of iron metabolism;Les outils biochimiques et hematologiques de l'exploration du metabolisme du fer

Archives de Pediatrie

Volumn 6, Issue 11, 1999, Pages 1199-1204

  Nathanson, S ^a   Deschenes G ^a   Bensman, A ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Assessment; Functional iron deficiency; Iron metabolism

Indexed keywords

HEMOGLOBIN; ERYTHROPOIETIN; FERRITIN; IRON;

ARTICLE; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; RETICULOCYTE; RISK ASSESSMENT; BONE MARROW; HEMATOPOIESIS; HUMAN; IRON DEFICIENCY ANEMIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANEMIA, IRON-DEFICIENCY; BONE MARROW; ERYTHROPOIETIN; FERRITINS; HEMATOPOIESIS; HUMANS; IRON;

EID: 0033229777     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(00)86305-8     Document Type: Article

References (21)

1. Cavill I. Disorders of iron metabolism. Diagnostic methods. Clin Haematol 1982; 11 : 259-73.
2. Skikne BS, Flowers CH, Cook D. Serum transferrin receptor: A quantitative measure of tissue iron deficiency. Blood 1990; 75 : 1870-6.
3. Drüecke TB, Barany P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, et al. Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin treated patients. Clin Nephrol 1997; 48 : 1-8.
4. Cazzola M, Beguin Y. New tools for clinical evaluation of erythron function in man. Br J Haematol 1992; 80 : 278-84.
5. Baynes RD, Cook JD. Current issues in iron deficiency. Curr Opin Hematol 1996; 3 : 145-9.
6. Baynes RD. Assessment of iron status. Clin Biochem 1996; 29 : 209-15.
7. Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89 : 1052-7.
8. Lipschitz DA, Cook ID, Finch CA. A clinical evalution of serum ferritin as an index of iron stores. N Engl J Med 1974; 290 : 1213-6.
9. Cazzola M, Ascari E. Red cell ferritin as a diagnostic tool. Br J Haematol 1986; 62 : 209-13.
10. Guillemin C, Revenant MC, Vernet M, Dezier JF, Charlier C, Paris M, et al. Erythrocyte ferritin. Ann Biol Clin 1993; 51 : 605-9.
11. Fishbane S. Lynn RI. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients. Am J Kidney Dis 1995; 25 : 426-32.
12. Worwood M. The laboratory assessment of iron status - An update. Clin Chim Acta 1997; 259 : 3-23.
13. Hörl WH. How to get the best out of r-HuEPO. Nephrol Dial Transplant 1995; 10 Suppl 2 : 92-5.
14. Hörl WH, Cavill I, Macdougall IC, Schaeffer RM, Sunder-Plassmann. How to diagnose and correct iron deficiency during rHuEPO therapy: A condensus report. Nephrol Dial Transplant 1996; 11 : 246-50.
15. Macdougall IC, Hutton RD, Cavill I, Coles GA, Williams JD. Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. Br Med 1989; 299 : 157-8.
16. Sunder-Plassmann G, Hörl WH. Erythropoietin and iron. Clin Nephrol 1997; 47 : 141-57.
17. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall S. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: Iron deficient erythropoietis in iron replete subjects. Blood 1993; 81 : 956-64.
18. Navarro JF, Macia ML. Hypochromic red cells as an indicator of iron deficiency. J Rheumatol 1997; 24 : 804-5.
19. Brugnara C, Hipp MJ, Irving PJ, Lathrop H, Lee PA, Minchello EM, et al. Automated reticulocyte counting and measurement of reticulocyte cellular indices. Am J Clin Pathol 1994; 102 : 623-32.
20. Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 1998; 28 : 1-11.
21. Cullen P, Söffker J, Höpfl M, Bremer C, Schlaghecker R, Mehrens T, et al. Hypochromic red cells and reticulocyte haemoglobin content as markers or iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999; 14 : 659-65.